| scholarly article | Q13442814 |
| P50 | author | Ruud Veldhuizen | Q60730440 |
| P2093 | author name string | James F Lewis | |
| Jaret L Malloy | |||
| Vijay P A Rasaiah | |||
| P2860 | cites work | Exogenous surfactant preserves lung function and reduces alveolar Evans blue dye influx in a rat model of ventilation-induced lung injury. | Q50523090 |
| Mechanical ventilation of isolated rat lungs changes the structure and biophysical properties of surfactant. | Q51727653 | ||
| Tidal ventilation at low airway pressures can augment lung injury. | Q55065976 | ||
| Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo | Q56655892 | ||
| Protein measurement with the Folin phenol reagent | Q20900776 | ||
| A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 | ||
| Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network | Q27861021 | ||
| Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome | Q34214892 | ||
| Pulmonary surfactant: functions, abnormalities and therapeutic options | Q34505410 | ||
| Pulsating bubble technique for evaluating pulmonary surfactant | Q36573848 | ||
| Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model | Q37364413 | ||
| Host defence capacities of pulmonary surfactant: evidence for 'non-surfactant' functions of the surfactant system | Q40575234 | ||
| Surfactant and the adult respiratory distress syndrome | Q40869111 | ||
| The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. | Q41752313 | ||
| Multiple system organ failure and the sepsis syndrome | Q42070839 | ||
| Pulmonary surfactant and inflammation in septic adult mice: role of surfactant protein A. | Q44776885 | ||
| Pulmonary surfactant: functions and molecular composition. | Q46027561 | ||
| P433 | issue | 5 | |
| P921 | main subject | acute respiratory distress syndrome | Q344873 |
| P304 | page(s) | L783-90 | |
| P577 | publication date | 2003-01-17 | |
| P1433 | published in | American Journal of Physiology - Lung Cellular and Molecular Physiology | Q4352992 |
| P1476 | title | Early surfactant administration protects against lung dysfunction in a mouse model of ARDS | |
| P478 | volume | 284 |
| Q33774273 | Administration of antenatal glucocorticoids and postnatal surfactant ameliorates respiratory distress syndrome-associated neonatal lethality in Erk3(-/-) mouse pups |
| Q46397319 | Apigenin Reduces NF-κB and Subsequent Cytokine Production as Protective Effect in a Rodent Animal Model of Lung Ischemia-Reperfusion Injury |
| Q36516307 | Effects of early administration of a novel anticholinergic drug on acute respiratory distress syndrome induced by sepsis |
| Q43125081 | Role of lung-marginated monocytes in an in vivo mouse model of ventilator-induced lung injury |
| Q53368920 | The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model. |
| Q35047639 | The effects of exogenous surfactant administration on ventilation-induced inflammation in mouse models of lung injury |
Search more.